ARCHIVES

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

In Brief: Rosenberg To Give Karnofsky Lecture at ASCO, Minna To Present Rosenthal Lecture At AACR

April 27, 1984

Working Group Beings AID-Related Lymphoma research

October 19, 1990

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982